3 results match your criteria: "WA and University of Washington School of Medicine[Affiliation]"

Fewer randomized clinical trials (RCTs) are conducted for chronic or recurrent pain in pediatric populations compared with adult populations; thus, data to support treatment efficacy in children are limited. This article evaluates the design features and reporting practices of RCTs for chronic and recurrent pain that are likely unique to, or particularly important in, a pediatric population to promote improvements in the evidence base for pediatric pain treatments. Areas covered include outcome measure selection and reporting and reporting of adverse events and challenges to recruitment and retention.

View Article and Find Full Text PDF

Novel therapies for diabetic kidney disease.

Adv Chronic Kidney Dis

March 2014

Providence Medical Research Center, Providence Sacred Heart Medical Center and Children's Hospital, Spokane, WA; and Providence Medical Research Center, Providence Sacred Heart Medical Center and Children's Hospital, Spokane, WA and University of Washington School of Medicine, Spokane and Seattle, WA.

The number of people diagnosed with diabetes is rising throughout the world, which in turn drives upward the global frequency of diabetic kidney disease (DKD). Individuals with DKD are at an increased risk for premature death, cardiovascular disease, and other severe illnesses that result in frequent hospitalizations and increased health-care utilization. Current treatments concentrate on controlling hyperglycemia and hypertension with the specific use of renin-angiotensin system inhibitors.

View Article and Find Full Text PDF